Kraig Biocraft Laboratories Announces BAM-1 Spider Silk Hybrids are in Production
ANN ARBOR, Mich., June 03, 2024 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) (“the Company” or “Kraig Labs”), announces today that Kraig Labs is now in production with its BAM-1 recombinant spider silk hybrids. The Company originally planned this launch for July, but the resounding successes of the production trials positioned Kraig Labs to accelerate its 2024 production schedule.
Related news for (KBLB)
- Microcaps in the Spotlight
- Closing Bell Spotlight: Momentum Names from Yesterday Continue to Roar
- Microcaps Leading the Late‑Day Charge
- Morning Market Snapshot: Small‑Caps and Bio Tools Jockey for Attention
- Kraig Labs Unlocks Spider Silk at Scale, Solving a Centuries-Old Problem of Nature’s Strongest Fiber